A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Recruiting · NCT07271667 · Registry updated 2026-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-06-12 | NCT07271667 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Curis, Inc. | 5 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Azienda Ospedale Università Padova | Padova | Italy | 5 |
| Azienda Ospedaliero Universitaria Maggiore della Carità | Novara | Italy | 14 |
| Hospital Universitario Fundación Jiménez Díaz - START MADRID | Madrid | Spain | 1 |
| IRCCS Ospedale San Raffaele | Milan | Italy | 85 |
| Mayo Clinic | Rochester | United States | 664 |
| MD Anderson Cancer Center Madrid | Madrid | Spain | 10 |
| Mt Sinai Comprehensive Cancer Center | Miami Beach | United States | 1 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| Summit Medical Group | Florham Park | United States | 14 |
| Texas Oncology - Sammons Cancer Center | Dallas | United States | 1 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |